Clinical trial
ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
NCT04912505 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 16, 2023
- Completion date
- January 2, 2024
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.